Vincent J. Picozzi

Vincent J. Picozzi

Oncology
1100 Ninth Avenue
Seattle, WA 98101

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications

Estimating the cost-effectiveness of tumor treating fields for locally advanced pancreatic cancer patients.

Estimating the cost-effectiveness of tumor treating fields for locally advanced pancreatic cancer patients.

Journal: Journal of medical economics
Published: July 28, 2026

Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study.

Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 31, 2025

Treatment of advanced pancreatic cancer: When will the third time be a charm?

Treatment of advanced pancreatic cancer: When will the third time be a charm?

Journal: Cancer
Published: August 14, 2024

Pancreatic enzyme replacement therapy in advanced adenocarcinoma of the pancreas improved overall survival: a retrospective, single institution study.

Pancreatic enzyme replacement therapy in advanced adenocarcinoma of the pancreas improved overall survival: a retrospective, single institution study.

Journal: The oncologist
Published: July 22, 2024

Keratin 17 is a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma.

Keratin 17 is a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma.

Journal: American journal of clinical pathology
Published: December 23, 2023

Alternating Gemcitabine/Nab-Paclitaxel (GA) and 5-FU/Leucovorin/Irinotecan (FOLFIRI) as First-Line Treatment for De Novo Metastatic Pancreatic Cancer (MPC): Safety and Effect.

Alternating Gemcitabine/Nab-Paclitaxel (GA) and 5-FU/Leucovorin/Irinotecan (FOLFIRI) as First-Line Treatment for De Novo Metastatic Pancreatic Cancer (MPC): Safety and Effect.

Journal: Cancers
Published: August 11, 2023

Pancreatic cancer: new approaches to drug therapy.

Pancreatic cancer: new approaches to drug therapy.

Journal: International journal of surgery (London, England)
Published: August 02, 2023

Efficacy and safety of abemaciclib alone and with PI3K/mTOR inhibitor LY3023414 or galunisertib versus chemotherapy in previously treated metastatic pancreatic adenocarcinoma: A randomized controlled trial.

Efficacy and safety of abemaciclib alone and with PI3K/mTOR inhibitor LY3023414 or galunisertib versus chemotherapy in previously treated metastatic pancreatic adenocarcinoma: A randomized controlled trial.

Journal: Cancer medicine
Published: April 18, 2023

Management of Patients With Pancreatic Cancer Using the "Right Track" Model.

Management of Patients With Pancreatic Cancer Using the "Right Track" Model.

Journal: The oncologist
Published: January 26, 2022

A randomized phase II study of SM-88 plus methoxsalen, phenytoin, and sirolimus in patients with metastatic pancreatic cancer treated in the second line and beyond.

A randomized phase II study of SM-88 plus methoxsalen, phenytoin, and sirolimus in patients with metastatic pancreatic cancer treated in the second line and beyond.

Journal: Cancer medicine
Published: December 10, 2021

Addressing unmet needs for people with cancer cachexia: recommendations from a multistakeholder workshop.

Addressing unmet needs for people with cancer cachexia: recommendations from a multistakeholder workshop.

Journal: Journal of cachexia, sarcopenia and muscle
Published: November 17, 2021

Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trial.

Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: December 24, 2020
Showing 1-12 of 42

Last Updated: 09/26/2026